StemCyte
Operates cord blood stem cell banks, and has supplied more than 1,400 cord blood products for more than 40 life-threatening diseases to more than 250 worldwide transplant centers. The company is actively involved in the development of new umbilical cord blood-based cell therapies. In addition, StemCyte offers private umbilical cord blood banking services to families to process and store their childs cord blood.
2011 STATISTICS
3-year growth:52%
2010 Revenue:$12.5 million
2007 Revenue:$8.3 million
Employees:265
Jobs added, prev. 3 years:115
PREVIOUS INC. 5000 RANKINGS
2010
2618
